Investigational Site 870 — Stockbridge, Georgia

Investigational Site 870 is a clinical research site located in Stockbridge, Georgia, United States.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Investigational Site 870 has participated in 1 clinical trials.

Therapeutic areas: Eosinophilic Asthma.

Sponsors: Teva Branded Pharmaceutical Products R&D, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site 870?

Investigational Site 870 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site 870 conducted?

Investigational Site 870 has 1 clinical trials on record. Their work covers Eosinophilic Asthma.

Is Investigational Site 870 accredited by Crixeo Health?

Investigational Site 870 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site 870?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.